HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase
2010
HCMV pUS28 Activates Pyk2 Kinase to Promote Cell Migration
publication
Evidence: moderate
Author Information
Author(s): Jennifer Vomaske, Susan Varnum, Ryan Melnychuk, Patricia Smith, Ljiljana Pasa-Tolic, Janani I. Shutthanandan, Daniel N. Streblow
Primary Institution: The Vaccine & Gene Therapy Institute, Oregon Health & Science University
Hypothesis
The study investigates the role of Pyk2 in pUS28-induced cellular motility.
Conclusion
The findings demonstrate that pUS28 signals through Pyk2 to enhance cellular motility, linking HCMV to glioblastoma cell activation.
Supporting Evidence
- pUS28 stimulation activates Pyk2 in a calcium-dependent manner.
- Expression of a mutant Pyk2 blocks SMC migration in response to CCL5.
- pUS28-mediated activation of RhoA occurs in glioblastoma cells.
Takeaway
This study shows that a protein from a virus can help cells move around, which might be important for understanding how some cancers grow.
Methodology
The study used in vitro migration assays and biochemical analyses to examine Pyk2's role in cellular motility.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website